These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

112 related items for PubMed ID: 16966512

  • 1. Combined antiviral-immunosuppressive treatment in human T-lymphotrophic virus 1-Sjögren-associated myelopathy.
    Pot C, Chizzolini C, Vokatch N, Tiercy JM, Ribi C, Landis T, Perren F.
    Arch Neurol; 2006 Sep; 63(9):1318-20. PubMed ID: 16966512
    [Abstract] [Full Text] [Related]

  • 2. Treatment of myelopathy in Sjögren syndrome with a combination of prednisone and cyclophosphamide.
    Williams CS, Butler E, Román GC.
    Arch Neurol; 2001 May; 58(5):815-9. PubMed ID: 11346378
    [Abstract] [Full Text] [Related]

  • 3. Human T-cell lymphotropic virus type 1-associated myelopathy, Sjögren syndrome, and lymphocytic pneumonitis.
    Kompoliti A, Gage B, Sharma L, Daniels JC.
    Arch Neurol; 1996 Sep; 53(9):940-2. PubMed ID: 8815861
    [Abstract] [Full Text] [Related]

  • 4. Primary Sjögren Syndrome in a Child with a Neuromyelitis Optica Spectrum Disorder.
    Kornitzer JM, Kimura Y, Janow GL.
    J Rheumatol; 2016 Jun; 43(6):1260-1. PubMed ID: 27252507
    [No Abstract] [Full Text] [Related]

  • 5. Acute progressive human T-lymphotropic virus type 1-associated myelopathy with Sjögren's syndrome: Cause or coincidence?
    Ueno T, Nishijima H, Kon T, Nunomura JI, Tomiyama M.
    J Neurol Sci; 2017 Feb 15; 373():33-34. PubMed ID: 28131215
    [No Abstract] [Full Text] [Related]

  • 6. Relationship between Sjögren's syndrome and human T-lymphotropic virus type I infection: follow-up study of 83 patients.
    Nakamura H, Kawakami A, Tominaga M, Hida A, Yamasaki S, Migita K, Kawabe Y, Nakamura T, Eguchi K.
    J Lab Clin Med; 2000 Feb 15; 135(2):139-44. PubMed ID: 10695658
    [Abstract] [Full Text] [Related]

  • 7. Myelopathies secondary to Sjögren's syndrome: treatment with monthly intravenous cyclophosphamide associated with corticosteroids.
    de Seze J, Delalande S, Fauchais AL, Hachulla E, Stojkovic T, Ferriby D, Hatron PY, Vermersch P.
    J Rheumatol; 2006 Apr 15; 33(4):709-11. PubMed ID: 16583474
    [Abstract] [Full Text] [Related]

  • 8. Reevaluation for clinical manifestations of HTLV-I-seropositive patients with Sjögren's syndrome.
    Nakamura H, Shimizu T, Takagi Y, Takahashi Y, Horai Y, Nakashima Y, Sato S, Shiraishi H, Nakamura T, Fukuoka J, Nakamura T, Kawakami A.
    BMC Musculoskelet Disord; 2015 Nov 04; 16():335. PubMed ID: 26537778
    [Abstract] [Full Text] [Related]

  • 9. Successful treatment of HTLV-1-related overlap syndrome using tacrolimus.
    Izumi Y, Kojima H, Koga Y, Yokota K, Mori H, Ohno T, Miyashita T, Ito M, Motomura M, Mine M, Ezaki H, Jiuchi Y, Niino D, Ohshima K, Migita K.
    Intern Med; 2011 Nov 04; 50(17):1849-53. PubMed ID: 21881287
    [Abstract] [Full Text] [Related]

  • 10. Pleural Effusion In A Patient With Primary Sjögren's Syndrome Successfully Treated With Corticosteroids.
    Cruz-Pérez Fdel P, Doval-Cortés A, Jaume-Anselmi F, Ramírez-Rivera J.
    Bol Asoc Med P R; 2015 Nov 04; 107(3):13-6. PubMed ID: 26742190
    [Abstract] [Full Text] [Related]

  • 11. [Myelopathy - Sjogren's syndrome association: analysis of clinical and radiological findings and clinical course].
    de Seze J, Stojkovic T, Hachulla E, Breteau G, Michon-Pasturel U, Mounier-Vehier F, Hatron PY, Vermersch P.
    Rev Neurol (Paris); 2001 Jul 04; 157(6-7):669-78. PubMed ID: 11458186
    [Abstract] [Full Text] [Related]

  • 12. [Potentially treatable subacute forms of infection due to the HTLV-1].
    Carod-Artal FJ, Melo M, Alves R, Brenner C, del Negro MC.
    Rev Neurol; 2001 Jul 04; 31(1):32-5. PubMed ID: 10948579
    [Abstract] [Full Text] [Related]

  • 13. Flow cytometry evaluation of the T-cell receptor Vbeta repertoire among human T-cell lymphotropic virus type-1 (HTLV-1) infected individuals: effect of interferon alpha therapy in HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP).
    Saito M, Nose H, Usuku K, Sabouri AH, Matsuzaki T, Izumo S, Arimura K, Osame M.
    J Neurol Sci; 2006 Jul 15; 246(1-2):37-43. PubMed ID: 16545396
    [Abstract] [Full Text] [Related]

  • 14. Application of immunosuppressant facilitates the therapy of optic neuritis combined with Sjögren's syndrome.
    Li H, Liu Z, Gong Y, Jiang Z, Zhang Y, Dai Y, Zhang Y, Wei S.
    Chin Med J (Engl); 2014 Jul 15; 127(17):3098-104. PubMed ID: 25189952
    [Abstract] [Full Text] [Related]

  • 15. HTLV-I virological and histopathological analysis in two cases of anti-centromere-antibody-seropositive Sjögren's syndrome.
    Nakamura H, Horai Y, Tokuyama A, Yoshimura S, Nakajima H, Ichinose K, Yamasaki S, Nakamura T, Hayashi T, Kawakami A.
    Mod Rheumatol; 2013 Jan 15; 23(1):133-9. PubMed ID: 22526828
    [Abstract] [Full Text] [Related]

  • 16. Tropical spastic paraparesis and HTLV-1 associated myelopathy: clinical, epidemiological, virological and therapeutic aspects.
    Gessain A, Mahieux R.
    Rev Neurol (Paris); 2012 Mar 15; 168(3):257-69. PubMed ID: 22405461
    [Abstract] [Full Text] [Related]

  • 17. Combined factor VIII and IX inhibitors in a non-haemophilic patient: successful treatment with immunosuppressive drugs.
    Carmassi F, Giannarelli C, De Giorgi A, De Negri F.
    Haemophilia; 2007 Jan 15; 13(1):106-7. PubMed ID: 17212735
    [Abstract] [Full Text] [Related]

  • 18. Behçet's disease and Sjögren syndrome in a patient with HTLV-I-associated myelopathy.
    Kanazawa H, Ijichi S, Eiraku N, Igakura T, Higuchi I, Nakagawa M, Kuriyama M, Tanaka S, Osame M.
    J Neurol Sci; 1993 Oct 15; 119(1):121-2. PubMed ID: 8246006
    [No Abstract] [Full Text] [Related]

  • 19. Detection of HTLV-1 in the labial salivary glands of patients with Sjögren’s syndrome: a distinct clinical subgroup?
    Lee SJ, Lee JS, Shin MG, Tanaka Y, Park DJ, Kim TJ, Park YW, Lee SS.
    J Rheumatol; 2012 Apr 15; 39(4):809-15. PubMed ID: 22382336
    [Abstract] [Full Text] [Related]

  • 20. Prospects for the management of human T-cell lymphotropic virus type 1-associated myelopathy.
    Martin F, Taylor GP.
    AIDS Rev; 2011 Apr 15; 13(3):161-70. PubMed ID: 21799534
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.